Fingolimod (Gilenya) and Ketamine Therapy | Tovani Health
Gilenya (Fingolimod) — Sphingosine 1-phosphate receptor modulator (relapsing MS)
Verdict at Tovani Health
Fully compatible; first-dose bradycardia monitoring is intrinsic to fingolimod.
Fingolimod and ketamine have no clinically significant interaction. Oral DMT for relapsing MS. The famous safety considerations are intrinsic and unchanged by KAP: first-dose bradycardia monitoring (6-hour observation at initiation), macular edema screening (ophthalmology baseline), lymphopenia and rare PML risk, and rebound disease activity if discontinued abruptly. These belong to fingolimod and neurology management.
If you take Gilenya regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Gilenya interacts with ketamine
Fingolimod is phosphorylated to its active S1P receptor modulator, sequestering lymphocytes in lymph nodes. CYP3A4 metabolism (substrate); strong inducers (rifampin) reduce levels meaningfully — that's an MS-team conversation independent of KAP.
What we do at intake
Continue as prescribed. Disclose your MS regimen and any recent lymphocyte count.
Bottom line
Fingolimod and ketamine have no clinically significant interaction. Oral DMT for relapsing MS. The famous safety considerations are intrinsic and unchanged by KAP: first-dose bradycardia monitoring (6-hour observation at initiation), macular edema screening (ophthalmology baseline), lymphopenia and rare PML risk, and rebound disease activity if discontinued abruptly. These belong to fingolimod and neurology management.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Gilenya (Fingolimod) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.